Cipla afrezza insulin price?

Cipla doesn’t manufacture Afrezza. Afrezza is the inhaled insulin brand from MannKind Corporation, and Cipla isn’t listed as its manufacturer. If you’re seeing a Cipla label, it might be a different insulin product, or a regional brand variant.

Prices for Afrezza vary a lot by country, dosage form (4-unit, 8-unit cartridges, etc.), and whether you have insurance or subsidies. In the U.S., Afrezza is a brand-name product with a relatively high out-of-pocket cost, and many patients use insurance to help cover it. Availability and pricing can be different or limited in other countries, and Afrezza isn’t broadly available in some markets.

If you’d like, tell me:
- Your country
- The exact product (how many units per cartridge, or if you’re asking about a Cipla-insulin product instead)
- Whether you want cash price or out-of-pocket with insurance

I can then give you more targeted guidance on where to check current prices and what to expect. And of course, consult your clinician or pharmacist for the most accurate price and suitability for your treatment.